Cargando…

Drug Resistance in Colorectal Cancer: From Mechanism to Clinic

SIMPLE SUMMARY: Chemotherapy, radiotherapy and molecularly targeted therapy could improve the prognosis of colorectal cancer (CRC) patients. Recently, immunotherapy, especially immune checkpoint inhibitors, has significantly improved the prognosis of some patients. However, drug resistance significa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qianyu, Shen, Xiaofei, Chen, Gang, Du, Junfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221177/ https://www.ncbi.nlm.nih.gov/pubmed/35740594 http://dx.doi.org/10.3390/cancers14122928

Ejemplares similares

The emerging role of neutrophil extracellular traps in cancer: from lab to ward
por: Zhong, Wentao, et al.
Publicado: (2023)

Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer
por: Wang, Qianyu, et al.
Publicado: (2022)

Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer
por: Duan, Lili, et al.
Publicado: (2020)

Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches
por: Cheng, Xiaofei, et al.
Publicado: (2023)

Targeting Neutrophils in Sepsis: From Mechanism to Translation
por: Shen, Xiaofei, et al.
Publicado: (2021)

Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond
por: Al Bitar, Samar, et al.
Publicado: (2023)

Drug resistance and new therapies in colorectal cancer
por: Van der Jeught, Kevin, et al.
Publicado: (2018)

Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
por: Li, Qing-Hai, et al.
Publicado: (2020)

Drug resistance related to aberrant glycosylation in colorectal cancer
por: Very, Ninon, et al.
Publicado: (2017)

Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer
por: Wang, Ke, et al.
Publicado: (2022)

The role and mechanisms of action of microRNAs in cancer drug resistance
por: Si, Wengong, et al.
Publicado: (2019)

Development of an Experimental Model for Analyzing Drug Resistance in Colorectal Cancer
por: Elbadawy, Mohamed, et al.
Publicado: (2018)

MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer
por: Jung, Eunsun, et al.
Publicado: (2021)

Mechanism and strategies of immunotherapy resistance in colorectal cancer
por: Shan, Jiqi, et al.
Publicado: (2022)

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects
por: Gmeiner, William H., et al.
Publicado: (2023)

Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
por: Song, Xiaohai, et al.
Publicado: (2023)

Drug‑resistant Acinetobacter baumannii: From molecular mechanisms to potential therapeutics (Review)
por: Wu, Hao-Jia, et al.
Publicado: (2023)

Drug resistance and combating drug resistance in cancer
por: Wang, Xuan, et al.
Publicado: (2019)

The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance
por: Lampropoulou, Dimitra Ioanna, et al.
Publicado: (2022)

Recent advances in targeted drug delivery systems for resistant colorectal cancer
por: Sharifi-Azad, Masoumeh, et al.
Publicado: (2022)

Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
por: Li, Sha, et al.
Publicado: (2022)

Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer
por: Guo, Yu, et al.
Publicado: (2022)

The application of extracellular vesicles in colorectal cancer metastasis and drug resistance: recent advances and trends
por: Xiong, Linjin, et al.
Publicado: (2023)

Pathological transition as the arising mechanism for drug resistance in lung cancer
por: Chen, Yueqing, et al.
Publicado: (2019)

Wnt/β-catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer
por: Zhu, Gui-Xian, et al.
Publicado: (2021)

Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer
por: Clarke, Paul A., et al.
Publicado: (2019)

Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions
por: Chen, Yu‐Fei, et al.
Publicado: (2022)

Drug resistance: from bacteria to cancer
por: Patel, Harsh, et al.
Publicado: (2021)

Characterization of the mechanism of Scutellaria baicalensis on reversing radio-resistance in colorectal cancer
por: Huang, Jinmei, et al.
Publicado: (2022)

5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
por: Blondy, Sabrina, et al.
Publicado: (2020)

DEHP mediates drug resistance by metabolic reprogramming in colorectal cancer cells
por: Wu, Yue, et al.
Publicado: (2023)

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
por: Zhou, Xuehao, et al.
Publicado: (2022)

Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
por: Yang, Qiurong, et al.
Publicado: (2022)

Mechanisms of Immunosuppression in Colorectal Cancer
por: Zhang, Yang, et al.
Publicado: (2020)

DNA damage and metabolic mechanisms of cancer drug resistance
por: Tiek, Deanna, et al.
Publicado: (2022)

Mechanisms of resistance to EGFR-targeted drugs: lung cancer
por: Morgillo, Floriana, et al.
Publicado: (2016)

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
por: Uribe, Mary Luz, et al.
Publicado: (2021)

Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
por: Kinnel, Briana, et al.
Publicado: (2023)

Inflammasomes in Colitis and Colorectal Cancer: Mechanism of Action and Therapies
por: Pandey, Abhimanu, et al.
Publicado: (2019)

Editorial: The role of immune checkpoints in gastrointestinal diseases
por: Shen, Xiaofei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fqnvr64e6dhee1s1id2or422t8